Shingo Tanaka

Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma

Shingo Tanaka, Koji Miyanishi, Masayoshi Kobune et al. · Journal of Gastroenterology · 2013 · 101 citations

Medicine, Molecular Biology, Pathology +16

Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer

Yasushi Sato, Tetsuji Takayama, Tamotsu Sagawa et al. · Cancer Chemotherapy and Pharmacology · 2009 · 81 citations

Medicine, Oncology, Pharmacotherapy +14

Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial

Masaharu Shinkai, Kenji Tsushima, Shingo Tanaka et al. · Infectious Diseases and Therapy · 2021 · 78 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Increased duodenal iron absorption through up‐regulation of divalent metal transporter 1 from enhancement of iron regulatory protein 1 activity in patients with nonalcoholic steatohepatitis

Toshifumi Hoki, Koji Miyanishi, Shingo Tanaka et al. · Hepatology · 2015 · 70 citations · Full text

Medicine, Biochemistry, Pathology +17

Obesity paradox in Japanese patients after percutaneous coronary intervention: An observation cohort study

Hidehiro Kaneko, Junji Yajima, Yuji Oikawa et al. · Journal of Cardiology · 2013 · 56 citations · Full text

Medicine, Cardiology, Interventional Cardiology +15